Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Dorsey

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|January 1, 1970
A comparison of serum immunoglobulin concentrations in sarcoidosis and tuberculosisC E Buckley, F C Dorsey
Annals of Internal Medicine|December 1, 1971
Addendum: immunoglobulins and ethnic groupsC E Buckley, F C Dorsey
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1970
The effect of aging on human serum immunoglobulin concentrationsC E Buckley, F C Dorsey
Annals of Internal Medicine|November 1, 1971
Serum immunoglobulin levels throughout the life-span of healthy manC E Buckley, F C Dorsey
American Heart Journal|September 1, 1991
Chagas' cardioneuropathy: effect of ganglioside treatment in chronic dysautonomic patients--a randomized, double-blind, parallel, placebo-controlled studyD Iosa, D C Massari, F C Dorsey
Annals of Emergency Medicine|June 1, 1993
Past and current clinical studies with GM-1 ganglioside in acute spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
Gerontologia|January 1, 1972
Age-dependent immunophysiologic correlates of chronic respiratory diseaseC E Buckley, F C Dorsey, H O Sieker
Journal of Neurotrauma|March 1, 1992
GM-1 ganglioside in human spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
The New England Journal of Medicine|December 5, 1991
Correction: recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 gangliosideF H Geisler, F C Dorsey, W P Coleman
Journal of Neurotrauma|May 1, 1992
GM-1 ganglioside in human spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|January 1, 1970
A comparison of serum immunoglobulin concentrations in sarcoidosis and tuberculosisC E Buckley, F C Dorsey
Annals of Internal Medicine|December 1, 1971
Addendum: immunoglobulins and ethnic groupsC E Buckley, F C Dorsey
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1970
The effect of aging on human serum immunoglobulin concentrationsC E Buckley, F C Dorsey
Annals of Internal Medicine|November 1, 1971
Serum immunoglobulin levels throughout the life-span of healthy manC E Buckley, F C Dorsey
American Heart Journal|September 1, 1991
Chagas' cardioneuropathy: effect of ganglioside treatment in chronic dysautonomic patients--a randomized, double-blind, parallel, placebo-controlled studyD Iosa, D C Massari, F C Dorsey
Annals of Emergency Medicine|June 1, 1993
Past and current clinical studies with GM-1 ganglioside in acute spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
Gerontologia|January 1, 1972
Age-dependent immunophysiologic correlates of chronic respiratory diseaseC E Buckley, F C Dorsey, H O Sieker
Journal of Neurotrauma|March 1, 1992
GM-1 ganglioside in human spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
The New England Journal of Medicine|December 5, 1991
Correction: recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 gangliosideF H Geisler, F C Dorsey, W P Coleman
Journal of Neurotrauma|May 1, 1992
GM-1 ganglioside in human spinal cord injuryF H Geisler, F C Dorsey, W P Coleman
Pageof 3